NCT06657144 2026-03-02A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsCoherus Oncology, Inc.Phase 1 Recruiting154 enrolled
NCT04137900 2024-02-05Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Recruiting499 enrolled